#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=1 .
1-1	0-1	1	quantity	new	_	_
1-2	2-3	.	_	_	_	_

#Text=Introduction
2-1	4-16	Introduction	abstract	new	_	_

#Text=Poultry production forms an integral part of the economy with many socio-economic and cultural values attached to the birds in most developing countries including Uganda .
3-1	17-24	Poultry	animal|abstract[4]	new|new[4]	coref|coref|coref|coref	4-10|4-9[13_4]|4-10|4-9[13_4]
3-2	25-35	production	abstract[4]	new[4]	_	_
3-3	36-41	forms	_	_	_	_
3-4	42-44	an	_	_	_	_
3-5	45-53	integral	_	_	_	_
3-6	54-58	part	_	_	_	_
3-7	59-61	of	_	_	_	_
3-8	62-65	the	abstract[5]	new[5]	_	_
3-9	66-73	economy	abstract[5]	new[5]	_	_
3-10	74-78	with	abstract[5]	new[5]	_	_
3-11	79-83	many	abstract[5]|abstract[6]	new[5]|new[6]	_	_
3-12	84-98	socio-economic	abstract[5]|abstract[6]	new[5]|new[6]	_	_
3-13	99-102	and	abstract[5]|abstract[6]	new[5]|new[6]	_	_
3-14	103-111	cultural	abstract[5]|abstract[6]	new[5]|new[6]	_	_
3-15	112-118	values	abstract[5]|abstract[6]	new[5]|new[6]	_	_
3-16	119-127	attached	_	_	_	_
3-17	128-130	to	_	_	_	_
3-18	131-134	the	animal[7]	new[7]	coref	6-30[0_7]
3-19	135-140	birds	animal[7]	new[7]	_	_
3-20	141-143	in	_	_	_	_
3-21	144-148	most	place[8]	new[8]	_	_
3-22	149-159	developing	place[8]	new[8]	_	_
3-23	160-169	countries	place[8]	new[8]	_	_
3-24	170-179	including	place[8]	new[8]	_	_
3-25	180-186	Uganda	place[8]|place	new[8]|new	coref	32-51
3-26	187-188	.	_	_	_	_

#Text=However , one of the major challenges to improved poultry production is the prevalence of poultry diseases that threaten the intensification of production .
4-1	189-196	However	_	_	_	_
4-2	197-198	,	_	_	_	_
4-3	199-202	one	abstract[10]	new[10]	coref	4-13[14_10]
4-4	203-205	of	abstract[10]	new[10]	_	_
4-5	206-209	the	abstract[10]|abstract[11]	new[10]|new[11]	_	_
4-6	210-215	major	abstract[10]|abstract[11]	new[10]|new[11]	_	_
4-7	216-226	challenges	abstract[10]|abstract[11]	new[10]|new[11]	_	_
4-8	227-229	to	abstract[10]|abstract[11]	new[10]|new[11]	_	_
4-9	230-238	improved	abstract[10]|abstract[11]|abstract[13]	new[10]|new[11]|giv[13]	coref	4-23[0_13]
4-10	239-246	poultry	abstract[10]|abstract[11]|animal|abstract[13]	new[10]|new[11]|giv|giv[13]	coref	4-16
4-11	247-257	production	abstract[10]|abstract[11]|abstract[13]	new[10]|new[11]|giv[13]	_	_
4-12	258-260	is	_	_	_	_
4-13	261-264	the	abstract[14]	giv[14]	_	_
4-14	265-275	prevalence	abstract[14]	giv[14]	_	_
4-15	276-278	of	abstract[14]	giv[14]	_	_
4-16	279-286	poultry	abstract[14]|animal|abstract[16]	giv[14]|giv|new[16]	coref|coref|coref|coref	5-4[19_16]|11-9[67_0]|5-4[19_16]|11-9[67_0]
4-17	287-295	diseases	abstract[14]|abstract[16]	giv[14]|new[16]	_	_
4-18	296-300	that	_	_	_	_
4-19	301-309	threaten	_	_	_	_
4-20	310-313	the	abstract[17]	new[17]	_	_
4-21	314-329	intensification	abstract[17]	new[17]	_	_
4-22	330-332	of	abstract[17]	new[17]	_	_
4-23	333-343	production	abstract[17]|abstract	new[17]|giv	coref	8-9[40_0]
4-24	344-345	.	_	_	_	_

#Text=Among these are gastrointestinal parasitic diseases notably , coccidiosis .
5-1	346-351	Among	_	_	_	_
5-2	352-357	these	_	_	_	_
5-3	358-361	are	_	_	_	_
5-4	362-378	gastrointestinal	abstract[19]	giv[19]	_	_
5-5	379-388	parasitic	abstract[19]	giv[19]	_	_
5-6	389-397	diseases	abstract[19]	giv[19]	_	_
5-7	398-405	notably	abstract[20]	new[20]	coref	6-1[0_20]
5-8	406-407	,	abstract[20]	new[20]	_	_
5-9	408-419	coccidiosis	abstract[20]	new[20]	_	_
5-10	420-421	.	_	_	_	_

#Text=Coccidiosis is a disease caused by parasites of the genus Eimeria and phylum Apicomplexa with a complex life cycle , affecting mainly the intestinal tract of many species of birds .
6-1	422-433	Coccidiosis	abstract	giv	coref	6-3[22_0]
6-2	434-436	is	_	_	_	_
6-3	437-438	a	abstract[22]	giv[22]	coref	8-5[0_22]
6-4	439-446	disease	abstract[22]	giv[22]	_	_
6-5	447-453	caused	_	_	_	_
6-6	454-456	by	_	_	_	_
6-7	457-466	parasites	animal[23]	new[23]	_	_
6-8	467-469	of	animal[23]	new[23]	_	_
6-9	470-473	the	animal[23]	new[23]	_	_
6-10	474-479	genus	animal[23]|abstract	new[23]|new	_	_
6-11	480-487	Eimeria	animal[23]	new[23]	_	_
6-12	488-491	and	animal[23]	new[23]	_	_
6-13	492-498	phylum	animal[23]|person|animal[26]	new[23]|new|new[26]	_	_
6-14	499-510	Apicomplexa	animal[23]|animal[26]	new[23]|new[26]	_	_
6-15	511-515	with	animal[23]	new[23]	_	_
6-16	516-517	a	animal[23]|abstract[28]	new[23]|new[28]	ana	7-1[0_28]
6-17	518-525	complex	animal[23]|abstract[28]	new[23]|new[28]	_	_
6-18	526-530	life	animal[23]|abstract|abstract[28]	new[23]|new|new[28]	coref	9-12
6-19	531-536	cycle	animal[23]|abstract[28]	new[23]|new[28]	_	_
6-20	537-538	,	_	_	_	_
6-21	539-548	affecting	_	_	_	_
6-22	549-555	mainly	_	_	_	_
6-23	556-559	the	object[29]	new[29]	_	_
6-24	560-570	intestinal	object[29]	new[29]	_	_
6-25	571-576	tract	object[29]	new[29]	_	_
6-26	577-579	of	object[29]	new[29]	_	_
6-27	580-584	many	object[29]|animal[30]	new[29]|new[30]	coref	14-6[92_30]
6-28	585-592	species	object[29]|animal[30]	new[29]|new[30]	_	_
6-29	593-595	of	object[29]|animal[30]	new[29]|new[30]	_	_
6-30	596-601	birds	object[29]|animal[30]|animal	new[29]|new[30]|giv	_	_
6-31	602-603	.	_	_	_	_

#Text=It is of great economic significance in farm animals , especially chickens .
7-1	604-606	It	abstract	giv	coref	9-11[53_0]
7-2	607-609	is	_	_	_	_
7-3	610-612	of	_	_	_	_
7-4	613-618	great	abstract[33]	new[33]	coref	8-1[37_33]
7-5	619-627	economic	abstract[33]	new[33]	_	_
7-6	628-640	significance	abstract[33]	new[33]	_	_
7-7	641-643	in	abstract[33]	new[33]	_	_
7-8	644-648	farm	abstract[33]|place|animal[35]	new[33]|new|new[35]	coref|coref|coref|coref	17-12[126_0]|18-5[0_35]|17-12[126_0]|18-5[0_35]
7-9	649-656	animals	abstract[33]|animal[35]	new[33]|new[35]	_	_
7-10	657-658	,	_	_	_	_
7-11	659-669	especially	animal[36]	new[36]	coref	14-37[0_36]
7-12	670-678	chickens	animal[36]	new[36]	_	_
7-13	679-680	.	_	_	_	_

#Text=The economic significance of coccidiosis is attributed to decreased animal production in terms of poor feed conversion , growth depression and increased mortality ; and the costs involved in treatment and prevention .
8-1	681-684	The	abstract[37]	giv[37]	_	_
8-2	685-693	economic	abstract[37]	giv[37]	_	_
8-3	694-706	significance	abstract[37]	giv[37]	_	_
8-4	707-709	of	abstract[37]	giv[37]	_	_
8-5	710-721	coccidiosis	abstract[37]|abstract	giv[37]|giv	coref	11-7
8-6	722-724	is	_	_	_	_
8-7	725-735	attributed	_	_	_	_
8-8	736-738	to	_	_	_	_
8-9	739-748	decreased	abstract[40]	giv[40]	coref	20-39[0_40]
8-10	749-755	animal	animal|abstract[40]	new|giv[40]	coref	15-15
8-11	756-766	production	abstract[40]	giv[40]	_	_
8-12	767-769	in	_	_	_	_
8-13	770-775	terms	_	_	_	_
8-14	776-778	of	_	_	_	_
8-15	779-783	poor	event[42]	new[42]	_	_
8-16	784-788	feed	substance|event[42]	new|new[42]	coref	12-11
8-17	789-799	conversion	event[42]	new[42]	_	_
8-18	800-801	,	_	_	_	_
8-19	802-808	growth	abstract|abstract[44]	new|new[44]	coref|coref	12-19[74_0]|12-19[74_0]
8-20	809-819	depression	abstract[44]	new[44]	_	_
8-21	820-823	and	_	_	_	_
8-22	824-833	increased	event[45]	new[45]	_	_
8-23	834-843	mortality	event[45]	new[45]	_	_
8-24	844-845	;	_	_	_	_
8-25	846-849	and	_	_	_	_
8-26	850-853	the	abstract[46]	new[46]	coref	11-1[65_46]
8-27	854-859	costs	abstract[46]	new[46]	_	_
8-28	860-868	involved	_	_	_	_
8-29	869-871	in	_	_	_	_
8-30	872-881	treatment	abstract	new	_	_
8-31	882-885	and	_	_	_	_
8-32	886-896	prevention	abstract	new	_	_
8-33	897-898	.	_	_	_	_

#Text=Pathogenesis entails Eimeria invading the intestinal cells as part of the life cycle .
9-1	899-911	Pathogenesis	abstract	new	_	_
9-2	912-919	entails	_	_	_	_
9-3	920-927	Eimeria	animal	new	coref	14-7
9-4	928-936	invading	_	_	_	_
9-5	937-940	the	place[51]	new[51]	_	_
9-6	941-951	intestinal	place[51]	new[51]	_	_
9-7	952-957	cells	place[51]	new[51]	_	_
9-8	958-960	as	_	_	_	_
9-9	961-965	part	_	_	_	_
9-10	966-968	of	_	_	_	_
9-11	969-972	the	abstract[53]	giv[53]	_	_
9-12	973-977	life	abstract|abstract[53]	giv|giv[53]	_	_
9-13	978-983	cycle	abstract[53]	giv[53]	_	_
9-14	984-985	.	_	_	_	_

#Text=The resulting intestinal damage impairs nutrients digestion and absorption , gut barrier function , and ultimately leads to bacterial infections particularly necrotic enteritis .
10-1	986-989	The	abstract[54]	new[54]	_	_
10-2	990-999	resulting	abstract[54]	new[54]	_	_
10-3	1000-1010	intestinal	abstract[54]	new[54]	_	_
10-4	1011-1017	damage	abstract[54]	new[54]	_	_
10-5	1018-1025	impairs	_	_	_	_
10-6	1026-1035	nutrients	substance|substance[56]	new|new[56]	_	_
10-7	1036-1045	digestion	substance[56]	new[56]	_	_
10-8	1046-1049	and	_	_	_	_
10-9	1050-1060	absorption	abstract	new	_	_
10-10	1061-1062	,	_	_	_	_
10-11	1063-1066	gut	abstract|abstract[60]	new|new[60]	coref|coref	19-15|19-15
10-12	1067-1074	barrier	object|abstract[60]	new|new[60]	_	_
10-13	1075-1083	function	abstract[60]	new[60]	_	_
10-14	1084-1085	,	_	_	_	_
10-15	1086-1089	and	_	_	_	_
10-16	1090-1100	ultimately	_	_	_	_
10-17	1101-1106	leads	_	_	_	_
10-18	1107-1109	to	_	_	_	_
10-19	1110-1119	bacterial	object|abstract[62]	new|new[62]	coref|coref|coref|coref	14-21|14-20[97_62]|14-21|14-20[97_62]
10-20	1120-1130	infections	abstract[62]	new[62]	_	_
10-21	1131-1143	particularly	object[63]	new[63]	_	_
10-22	1144-1152	necrotic	object[63]	new[63]	_	_
10-23	1153-1162	enteritis	object[63]	new[63]	_	_
10-24	1163-1164	.	_	_	_	_

#Text=The global annual costs inflicted by coccidiosis to commercial poultry have been estimated at 2 billion â‚¬ .
11-1	1165-1168	The	abstract[65]	giv[65]	_	_
11-2	1169-1175	global	abstract[65]	giv[65]	_	_
11-3	1176-1182	annual	time|abstract[65]	new|giv[65]	_	_
11-4	1183-1188	costs	abstract[65]	giv[65]	_	_
11-5	1189-1198	inflicted	_	_	_	_
11-6	1199-1201	by	_	_	_	_
11-7	1202-1213	coccidiosis	abstract	giv	coref	13-20
11-8	1214-1216	to	_	_	_	_
11-9	1217-1227	commercial	animal[67]	giv[67]	coref	12-23[0_67]
11-10	1228-1235	poultry	animal[67]	giv[67]	_	_
11-11	1236-1240	have	_	_	_	_
11-12	1241-1245	been	_	_	_	_
11-13	1246-1255	estimated	_	_	_	_
11-14	1256-1258	at	_	_	_	_
11-15	1259-1260	2	quantity[68]	new[68]	_	_
11-16	1261-1268	billion	quantity[68]	new[68]	_	_
11-17	1269-1270	â‚¬	_	_	_	_
11-18	1271-1272	.	_	_	_	_

#Text=For the past 5 decades , the use of anti-coccidial feed additives has played a major role in the growth of the poultry industry facilitating increased availability of quality and affordable poultry products to the consumers .
12-1	1273-1276	For	_	_	_	_
12-2	1277-1280	the	time[69]	new[69]	coref	19-3[138_69]
12-3	1281-1285	past	time[69]	new[69]	_	_
12-4	1286-1287	5	time[69]	new[69]	_	_
12-5	1288-1295	decades	time[69]	new[69]	_	_
12-6	1296-1297	,	_	_	_	_
12-7	1298-1301	the	abstract[70]	new[70]	_	_
12-8	1302-1305	use	abstract[70]	new[70]	_	_
12-9	1306-1308	of	abstract[70]	new[70]	_	_
12-10	1309-1323	anti-coccidial	abstract[70]|abstract[72]	new[70]|new[72]	_	_
12-11	1324-1328	feed	abstract[70]|substance|abstract[72]	new[70]|giv|new[72]	_	_
12-12	1329-1338	additives	abstract[70]|abstract[72]	new[70]|new[72]	_	_
12-13	1339-1342	has	_	_	_	_
12-14	1343-1349	played	_	_	_	_
12-15	1350-1351	a	abstract[73]	new[73]	_	_
12-16	1352-1357	major	abstract[73]	new[73]	_	_
12-17	1358-1362	role	abstract[73]	new[73]	_	_
12-18	1363-1365	in	abstract[73]	new[73]	_	_
12-19	1366-1369	the	abstract[73]|abstract[74]	new[73]|giv[74]	coref	21-34[0_74]
12-20	1370-1376	growth	abstract[73]|abstract[74]	new[73]|giv[74]	_	_
12-21	1377-1379	of	abstract[73]|abstract[74]	new[73]|giv[74]	_	_
12-22	1380-1383	the	abstract[73]|abstract[74]|abstract[76]	new[73]|giv[74]|new[76]	_	_
12-23	1384-1391	poultry	abstract[73]|abstract[74]|animal|abstract[76]	new[73]|giv[74]|giv|new[76]	coref	12-32
12-24	1392-1400	industry	abstract[73]|abstract[74]|abstract[76]	new[73]|giv[74]|new[76]	_	_
12-25	1401-1413	facilitating	_	_	_	_
12-26	1414-1423	increased	event[77]	new[77]	_	_
12-27	1424-1436	availability	event[77]	new[77]	_	_
12-28	1437-1439	of	event[77]	new[77]	_	_
12-29	1440-1447	quality	event[77]|abstract	new[77]|new	coref	29-27[241_0]
12-30	1448-1451	and	event[77]	new[77]	_	_
12-31	1452-1462	affordable	event[77]|object[80]	new[77]|new[80]	coref	15-15[109_80]
12-32	1463-1470	poultry	event[77]|animal|object[80]	new[77]|giv|new[80]	coref	16-21
12-33	1471-1479	products	event[77]|object[80]	new[77]|new[80]	_	_
12-34	1480-1482	to	event[77]|object[80]	new[77]|new[80]	_	_
12-35	1483-1486	the	event[77]|object[80]|person[81]	new[77]|new[80]|new[81]	_	_
12-36	1487-1496	consumers	event[77]|object[80]|person[81]	new[77]|new[80]|new[81]	_	_
12-37	1497-1498	.	_	_	_	_

#Text=However , some degree of resistance to all anticoccidial drugs , including ionophores which are now the mainstay of coccidiosis control has been reported .
13-1	1499-1506	However	_	_	_	_
13-2	1507-1508	,	_	_	_	_
13-3	1509-1513	some	abstract[82]	new[82]	_	_
13-4	1514-1520	degree	abstract[82]	new[82]	_	_
13-5	1521-1523	of	abstract[82]	new[82]	_	_
13-6	1524-1534	resistance	abstract[82]|abstract[83]	new[82]|new[83]	coref	16-17[120_83]
13-7	1535-1537	to	abstract[82]|abstract[83]	new[82]|new[83]	_	_
13-8	1538-1541	all	abstract[82]|abstract[83]|substance[84]	new[82]|new[83]|new[84]	coref	14-11[93_84]
13-9	1542-1555	anticoccidial	abstract[82]|abstract[83]|substance[84]	new[82]|new[83]|new[84]	_	_
13-10	1556-1561	drugs	abstract[82]|abstract[83]|substance[84]	new[82]|new[83]|new[84]	_	_
13-11	1562-1563	,	abstract[82]	new[82]	_	_
13-12	1564-1573	including	abstract[82]	new[82]	_	_
13-13	1574-1584	ionophores	abstract[82]|substance	new[82]|new	_	_
13-14	1585-1590	which	_	_	_	_
13-15	1591-1594	are	_	_	_	_
13-16	1595-1598	now	abstract[86]	new[86]	_	_
13-17	1599-1602	the	abstract[86]	new[86]	_	_
13-18	1603-1611	mainstay	abstract[86]	new[86]	_	_
13-19	1612-1614	of	abstract[86]	new[86]	_	_
13-20	1615-1626	coccidiosis	abstract[86]|abstract|abstract[88]	new[86]|giv|new[88]	coref|coref|coref|coref	15-27[113_88]|16-3|15-27[113_88]|16-3
13-21	1627-1634	control	abstract[86]|abstract[88]	new[86]|new[88]	_	_
13-22	1635-1638	has	_	_	_	_
13-23	1639-1643	been	_	_	_	_
13-24	1644-1652	reported	_	_	_	_
13-25	1653-1654	.	_	_	_	_

#Text=Concerns over the development of resistant Eimeria species to existing anticoccidial drugs and restrictive use of antibiotics to control secondary bacterial infections further stresses the urgent need to explore alternative strategies for maintaining intestinal functionality in chickens .
14-1	1655-1663	Concerns	abstract[89]	new[89]	coref	15-8[105_89]
14-2	1664-1668	over	abstract[89]	new[89]	_	_
14-3	1669-1672	the	abstract[89]|event[90]	new[89]|new[90]	_	_
14-4	1673-1684	development	abstract[89]|event[90]	new[89]|new[90]	_	_
14-5	1685-1687	of	abstract[89]|event[90]	new[89]|new[90]	_	_
14-6	1688-1697	resistant	abstract[89]|event[90]|animal[92]	new[89]|new[90]|giv[92]	_	_
14-7	1698-1705	Eimeria	abstract[89]|event[90]|animal|animal[92]	new[89]|new[90]|giv|giv[92]	_	_
14-8	1706-1713	species	abstract[89]|event[90]|animal[92]	new[89]|new[90]|giv[92]	_	_
14-9	1714-1716	to	_	_	_	_
14-10	1717-1725	existing	_	_	_	_
14-11	1726-1739	anticoccidial	substance[93]	giv[93]	_	_
14-12	1740-1745	drugs	substance[93]	giv[93]	_	_
14-13	1746-1749	and	substance[93]	giv[93]	_	_
14-14	1750-1761	restrictive	substance[93]|abstract[94]	giv[93]|new[94]	_	_
14-15	1762-1765	use	substance[93]|abstract[94]	giv[93]|new[94]	_	_
14-16	1766-1768	of	substance[93]|abstract[94]	giv[93]|new[94]	_	_
14-17	1769-1780	antibiotics	substance[93]|abstract[94]|object	giv[93]|new[94]|new	coref	20-4[146_0]
14-18	1781-1783	to	_	_	_	_
14-19	1784-1791	control	_	_	_	_
14-20	1792-1801	secondary	abstract[97]	giv[97]	_	_
14-21	1802-1811	bacterial	object|abstract[97]	giv|giv[97]	_	_
14-22	1812-1822	infections	abstract[97]	giv[97]	_	_
14-23	1823-1830	further	_	_	_	_
14-24	1831-1839	stresses	_	_	_	_
14-25	1840-1843	the	abstract[98]	new[98]	coref	15-18[110_98]
14-26	1844-1850	urgent	abstract[98]	new[98]	_	_
14-27	1851-1855	need	abstract[98]	new[98]	_	_
14-28	1856-1858	to	_	_	_	_
14-29	1859-1866	explore	_	_	_	_
14-30	1867-1878	alternative	abstract[99]	new[99]	coref	15-24[112_99]
14-31	1879-1889	strategies	abstract[99]	new[99]	_	_
14-32	1890-1893	for	_	_	_	_
14-33	1894-1905	maintaining	_	_	_	_
14-34	1906-1916	intestinal	abstract[100]	new[100]	_	_
14-35	1917-1930	functionality	abstract[100]	new[100]	_	_
14-36	1931-1933	in	_	_	_	_
14-37	1934-1942	chickens	animal	giv	coref	19-18
14-38	1943-1944	.	_	_	_	_

#Text=In addition , serious public health and food safety concerns regarding drug residues in animal products highlight the need for researchers to develop alternative strategies for the control of parasitic problems .
15-1	1945-1947	In	_	_	_	_
15-2	1948-1956	addition	_	_	_	_
15-3	1957-1958	,	_	_	_	_
15-4	1959-1966	serious	abstract[102]	new[102]	coref	32-31[272_102]
15-5	1967-1973	public	abstract[102]	new[102]	_	_
15-6	1974-1980	health	abstract[102]	new[102]	_	_
15-7	1981-1984	and	_	_	_	_
15-8	1985-1989	food	substance|abstract[105]	new|giv[105]	_	_
15-9	1990-1996	safety	abstract|abstract[105]	new|giv[105]	_	_
15-10	1997-2005	concerns	abstract[105]	giv[105]	_	_
15-11	2006-2015	regarding	_	_	_	_
15-12	2016-2020	drug	substance|substance[107]	new|new[107]	coref|coref	16-18|16-18
15-13	2021-2029	residues	substance[107]	new[107]	_	_
15-14	2030-2032	in	substance[107]	new[107]	_	_
15-15	2033-2039	animal	substance[107]|animal|object[109]	new[107]|giv|giv[109]	_	_
15-16	2040-2048	products	substance[107]|object[109]	new[107]|giv[109]	_	_
15-17	2049-2058	highlight	_	_	_	_
15-18	2059-2062	the	abstract[110]	giv[110]	_	_
15-19	2063-2067	need	abstract[110]	giv[110]	_	_
15-20	2068-2071	for	abstract[110]	giv[110]	_	_
15-21	2072-2083	researchers	abstract[110]|person	giv[110]|new	_	_
15-22	2084-2086	to	_	_	_	_
15-23	2087-2094	develop	_	_	_	_
15-24	2095-2106	alternative	abstract[112]	giv[112]	coref	17-8[125_112]
15-25	2107-2117	strategies	abstract[112]	giv[112]	_	_
15-26	2118-2121	for	_	_	_	_
15-27	2122-2125	the	abstract[113]	giv[113]	coref	16-12[118_113]
15-28	2126-2133	control	abstract[113]	giv[113]	_	_
15-29	2134-2136	of	abstract[113]	giv[113]	_	_
15-30	2137-2146	parasitic	abstract[113]|abstract[114]	giv[113]|new[114]	_	_
15-31	2147-2155	problems	abstract[113]|abstract[114]	giv[113]|new[114]	_	_
15-32	2156-2157	.	_	_	_	_

#Text=Vaccines for coccidiosis have been reported as an effective tool for disease control and to ameliorate anticoccidial drug resistance in poultry .
16-1	2158-2166	Vaccines	abstract[115]	new[115]	ana	17-3[0_115]
16-2	2167-2170	for	abstract[115]	new[115]	_	_
16-3	2171-2182	coccidiosis	abstract[115]|abstract	new[115]|giv	coref	16-12
16-4	2183-2187	have	_	_	_	_
16-5	2188-2192	been	_	_	_	_
16-6	2193-2201	reported	_	_	_	_
16-7	2202-2204	as	_	_	_	_
16-8	2205-2207	an	_	_	_	_
16-9	2208-2217	effective	_	_	_	_
16-10	2218-2222	tool	_	_	_	_
16-11	2223-2226	for	_	_	_	_
16-12	2227-2234	disease	abstract|abstract[118]	giv|giv[118]	coref|coref	21-31|21-31
16-13	2235-2242	control	abstract[118]	giv[118]	_	_
16-14	2243-2246	and	_	_	_	_
16-15	2247-2249	to	_	_	_	_
16-16	2250-2260	ameliorate	_	_	_	_
16-17	2261-2274	anticoccidial	abstract[120]	giv[120]	_	_
16-18	2275-2279	drug	substance|abstract[120]	giv|giv[120]	_	_
16-19	2280-2290	resistance	abstract[120]	giv[120]	_	_
16-20	2291-2293	in	abstract[120]	giv[120]	_	_
16-21	2294-2301	poultry	abstract[120]|animal	giv[120]|giv	coref	20-38
16-22	2302-2303	.	_	_	_	_

#Text=However , their efficacy depends greatly on the management strategies in a farm .
17-1	2304-2311	However	_	_	_	_
17-2	2312-2313	,	_	_	_	_
17-3	2314-2319	their	abstract|abstract[123]	giv|new[123]	ana|coref|ana|coref	21-29|30-3[242_123]|21-29|30-3[242_123]
17-4	2320-2328	efficacy	abstract[123]	new[123]	_	_
17-5	2329-2336	depends	_	_	_	_
17-6	2337-2344	greatly	_	_	_	_
17-7	2345-2347	on	_	_	_	_
17-8	2348-2351	the	abstract[125]	giv[125]	_	_
17-9	2352-2362	management	person|abstract[125]	new|giv[125]	_	_
17-10	2363-2373	strategies	abstract[125]	giv[125]	_	_
17-11	2374-2376	in	abstract[125]	giv[125]	_	_
17-12	2377-2378	a	abstract[125]|place[126]	giv[125]|giv[126]	_	_
17-13	2379-2383	farm	abstract[125]|place[126]	giv[125]|giv[126]	_	_
17-14	2384-2385	.	_	_	_	_

#Text=The digestive tract of animals harbors a great number of living and metabolizing microorganisms ( microbiota ) , that not only influence physiological functions of the host , but are also considered fundamental for a proper development of several vital traits , including immune system .
18-1	2386-2389	The	object[127]	new[127]	_	_
18-2	2390-2399	digestive	object[127]	new[127]	_	_
18-3	2400-2405	tract	object[127]	new[127]	_	_
18-4	2406-2408	of	object[127]	new[127]	_	_
18-5	2409-2416	animals	object[127]|animal	new[127]|giv	coref	20-26
18-6	2417-2424	harbors	_	_	_	_
18-7	2425-2426	a	abstract[129]	new[129]	_	_
18-8	2427-2432	great	abstract[129]	new[129]	_	_
18-9	2433-2439	number	abstract[129]	new[129]	_	_
18-10	2440-2442	of	abstract[129]	new[129]	_	_
18-11	2443-2449	living	abstract[129]	new[129]	_	_
18-12	2450-2453	and	abstract[129]	new[129]	_	_
18-13	2454-2466	metabolizing	abstract[129]|animal[130]	new[129]|new[130]	appos	18-16[0_130]
18-14	2467-2481	microorganisms	abstract[129]|animal[130]	new[129]|new[130]	_	_
18-15	2482-2483	(	_	_	_	_
18-16	2484-2494	microbiota	animal	giv	_	_
18-17	2495-2496	)	_	_	_	_
18-18	2497-2498	,	_	_	_	_
18-19	2499-2503	that	_	_	_	_
18-20	2504-2507	not	_	_	_	_
18-21	2508-2512	only	_	_	_	_
18-22	2513-2522	influence	_	_	_	_
18-23	2523-2536	physiological	abstract[132]	new[132]	_	_
18-24	2537-2546	functions	abstract[132]	new[132]	_	_
18-25	2547-2549	of	abstract[132]	new[132]	_	_
18-26	2550-2553	the	abstract[132]|animal[133]	new[132]|new[133]	coref	29-18[237_133]
18-27	2554-2558	host	abstract[132]|animal[133]	new[132]|new[133]	_	_
18-28	2559-2560	,	_	_	_	_
18-29	2561-2564	but	_	_	_	_
18-30	2565-2568	are	_	_	_	_
18-31	2569-2573	also	_	_	_	_
18-32	2574-2584	considered	_	_	_	_
18-33	2585-2596	fundamental	_	_	_	_
18-34	2597-2600	for	_	_	_	_
18-35	2601-2602	a	event[134]	new[134]	_	_
18-36	2603-2609	proper	event[134]	new[134]	_	_
18-37	2610-2621	development	event[134]	new[134]	_	_
18-38	2622-2624	of	event[134]	new[134]	_	_
18-39	2625-2632	several	event[134]|abstract[135]	new[134]|new[135]	coref	32-24[268_135]
18-40	2633-2638	vital	event[134]|abstract[135]	new[134]|new[135]	_	_
18-41	2639-2645	traits	event[134]|abstract[135]	new[134]|new[135]	_	_
18-42	2646-2647	,	event[134]|abstract[135]	new[134]|new[135]	_	_
18-43	2648-2657	including	event[134]|abstract[135]	new[134]|new[135]	_	_
18-44	2658-2664	immune	event[134]|abstract[135]|abstract|abstract[137]	new[134]|new[135]|new|new[137]	coref|coref|coref|coref	21-20|21-18[166_137]|21-20|21-18[166_137]
18-45	2665-2671	system	event[134]|abstract[135]|abstract[137]	new[134]|new[135]|new[137]	_	_
18-46	2672-2673	.	_	_	_	_

#Text=Thus , the past decades , have seen much effort going into optimizing the gut microbiota of chickens using dietary interventions .
19-1	2674-2678	Thus	_	_	_	_
19-2	2679-2680	,	_	_	_	_
19-3	2681-2684	the	time[138]	giv[138]	_	_
19-4	2685-2689	past	time[138]	giv[138]	_	_
19-5	2690-2697	decades	time[138]	giv[138]	_	_
19-6	2698-2699	,	_	_	_	_
19-7	2700-2704	have	_	_	_	_
19-8	2705-2709	seen	_	_	_	_
19-9	2710-2714	much	abstract[139]	new[139]	_	_
19-10	2715-2721	effort	abstract[139]	new[139]	_	_
19-11	2722-2727	going	_	_	_	_
19-12	2728-2732	into	_	_	_	_
19-13	2733-2743	optimizing	_	_	_	_
19-14	2744-2747	the	abstract[141]	new[141]	coref	28-34[230_141]
19-15	2748-2751	gut	abstract|abstract[141]	giv|new[141]	coref	32-31
19-16	2752-2762	microbiota	abstract[141]	new[141]	_	_
19-17	2763-2765	of	abstract[141]	new[141]	_	_
19-18	2766-2774	chickens	abstract[141]|animal	new[141]|giv	coref	25-9
19-19	2775-2780	using	_	_	_	_
19-20	2781-2788	dietary	abstract|abstract[144]	new|new[144]	_	_
19-21	2789-2802	interventions	abstract[144]	new[144]	_	_
19-22	2803-2804	.	_	_	_	_

#Text=Although use of antibiotics at subtherapeutic levels has been the most popular and perhaps the most effective strategy to enhance feed efficiency and to keep animals healthy , the approach is no longer a feasible tool for poultry production performance enhancement due to its ban by the EU in 2006 .
20-1	2805-2813	Although	_	_	_	_
20-2	2814-2817	use	abstract[145]	new[145]	_	_
20-3	2818-2820	of	abstract[145]	new[145]	_	_
20-4	2821-2832	antibiotics	abstract[145]|object[146]	new[145]|giv[146]	coref	21-41[0_146]
20-5	2833-2835	at	abstract[145]|object[146]	new[145]|giv[146]	_	_
20-6	2836-2850	subtherapeutic	abstract[145]|object[146]|abstract[147]	new[145]|giv[146]|new[147]	_	_
20-7	2851-2857	levels	abstract[145]|object[146]|abstract[147]	new[145]|giv[146]|new[147]	_	_
20-8	2858-2861	has	_	_	_	_
20-9	2862-2866	been	_	_	_	_
20-10	2867-2870	the	abstract[148]	new[148]	_	_
20-11	2871-2875	most	abstract[148]	new[148]	_	_
20-12	2876-2883	popular	abstract[148]	new[148]	_	_
20-13	2884-2887	and	abstract[148]	new[148]	_	_
20-14	2888-2895	perhaps	abstract[148]	new[148]	_	_
20-15	2896-2899	the	abstract[148]	new[148]	_	_
20-16	2900-2904	most	abstract[148]	new[148]	_	_
20-17	2905-2914	effective	abstract[148]	new[148]	_	_
20-18	2915-2923	strategy	abstract[148]	new[148]	_	_
20-19	2924-2926	to	_	_	_	_
20-20	2927-2934	enhance	_	_	_	_
20-21	2935-2939	feed	_	_	_	_
20-22	2940-2950	efficiency	abstract	new	_	_
20-23	2951-2954	and	_	_	_	_
20-24	2955-2957	to	_	_	_	_
20-25	2958-2962	keep	_	_	_	_
20-26	2963-2970	animals	animal	giv	coref	24-17[187_0]
20-27	2971-2978	healthy	_	_	_	_
20-28	2979-2980	,	_	_	_	_
20-29	2981-2984	the	abstract[151]	new[151]	coref	20-33[152_151]
20-30	2985-2993	approach	abstract[151]	new[151]	_	_
20-31	2994-2996	is	_	_	_	_
20-32	2997-2999	no	_	_	_	_
20-33	3000-3006	longer	abstract[152]	giv[152]	_	_
20-34	3007-3008	a	abstract[152]	giv[152]	_	_
20-35	3009-3017	feasible	abstract[152]	giv[152]	_	_
20-36	3018-3022	tool	abstract[152]	giv[152]	_	_
20-37	3023-3026	for	abstract[152]	giv[152]	_	_
20-38	3027-3034	poultry	abstract[152]|animal|abstract[156]	giv[152]|giv|new[156]	ana|ana	20-44[0_156]|20-44[0_156]
20-39	3035-3045	production	abstract[152]|abstract|abstract[156]	giv[152]|giv|new[156]	_	_
20-40	3046-3057	performance	abstract[152]|abstract|abstract[156]	giv[152]|new|new[156]	coref	21-34[171_0]
20-41	3058-3069	enhancement	abstract[152]|abstract[156]	giv[152]|new[156]	_	_
20-42	3070-3073	due	_	_	_	_
20-43	3074-3076	to	_	_	_	_
20-44	3077-3080	its	abstract|event[158]	giv|new[158]	_	_
20-45	3081-3084	ban	event[158]	new[158]	_	_
20-46	3085-3087	by	event[158]	new[158]	_	_
20-47	3088-3091	the	event[158]|place[159]	new[158]|new[159]	_	_
20-48	3092-3094	EU	event[158]|place[159]	new[158]|new[159]	_	_
20-49	3095-3097	in	event[158]	new[158]	_	_
20-50	3098-3102	2006	event[158]|time	new[158]|new	_	_
20-51	3103-3104	.	_	_	_	_

#Text=Incorporation of immunobiotics , particularly lactic acid bacteria is thought to be useful as immunomodulators to stimulate the gut-associated immune system in neonatal chicks , and thereby protect them from disease without decreasing growth performance as a possible substitution of antibiotics .
21-1	3105-3118	Incorporation	abstract[161]	new[161]	_	_
21-2	3119-3121	of	abstract[161]	new[161]	_	_
21-3	3122-3135	immunobiotics	abstract[161]|substance	new[161]|new	_	_
21-4	3136-3137	,	abstract[161]	new[161]	_	_
21-5	3138-3150	particularly	abstract[161]|abstract[163]|substance[164]	new[161]|new[163]|new[164]	_	_
21-6	3151-3157	lactic	abstract[161]|abstract[163]|substance[164]	new[161]|new[163]|new[164]	_	_
21-7	3158-3162	acid	abstract[161]|substance[164]	new[161]|new[164]	_	_
21-8	3163-3171	bacteria	abstract[161]|substance[164]	new[161]|new[164]	_	_
21-9	3172-3174	is	_	_	_	_
21-10	3175-3182	thought	_	_	_	_
21-11	3183-3185	to	_	_	_	_
21-12	3186-3188	be	_	_	_	_
21-13	3189-3195	useful	_	_	_	_
21-14	3196-3198	as	_	_	_	_
21-15	3199-3215	immunomodulators	_	_	_	_
21-16	3216-3218	to	_	_	_	_
21-17	3219-3228	stimulate	_	_	_	_
21-18	3229-3232	the	abstract[166]	giv[166]	_	_
21-19	3233-3247	gut-associated	abstract[166]	giv[166]	_	_
21-20	3248-3254	immune	abstract|abstract[166]	giv|giv[166]	coref	29-15
21-21	3255-3261	system	abstract[166]	giv[166]	_	_
21-22	3262-3264	in	abstract[166]	giv[166]	_	_
21-23	3265-3273	neonatal	abstract[166]|animal[167]	giv[166]|new[167]	coref	27-41[216_167]
21-24	3274-3280	chicks	abstract[166]|animal[167]	giv[166]|new[167]	_	_
21-25	3281-3282	,	_	_	_	_
21-26	3283-3286	and	_	_	_	_
21-27	3287-3294	thereby	_	_	_	_
21-28	3295-3302	protect	_	_	_	_
21-29	3303-3307	them	abstract	giv	_	_
21-30	3308-3312	from	_	_	_	_
21-31	3313-3320	disease	abstract	giv	coref	23-20[183_0]
21-32	3321-3328	without	_	_	_	_
21-33	3329-3339	decreasing	_	_	_	_
21-34	3340-3346	growth	abstract|abstract[171]	giv|giv[171]	coref|coref|coref|coref	29-25[0_171]|32-21|29-25[0_171]|32-21
21-35	3347-3358	performance	abstract[171]	giv[171]	_	_
21-36	3359-3361	as	_	_	_	_
21-37	3362-3363	a	_	_	_	_
21-38	3364-3372	possible	_	_	_	_
21-39	3373-3385	substitution	_	_	_	_
21-40	3386-3388	of	_	_	_	_
21-41	3389-3400	antibiotics	object	giv	_	_
21-42	3401-3402	.	_	_	_	_

#Text=Prebiotics , which are defined as non-digestible oligosaccharides , are also potent modulators of the intestinal microflora .
22-1	3403-3413	Prebiotics	abstract	new	coref	22-12[174_0]
22-2	3414-3415	,	_	_	_	_
22-3	3416-3421	which	_	_	_	_
22-4	3422-3425	are	_	_	_	_
22-5	3426-3433	defined	_	_	_	_
22-6	3434-3436	as	_	_	_	_
22-7	3437-3451	non-digestible	_	_	_	_
22-8	3452-3468	oligosaccharides	_	_	_	_
22-9	3469-3470	,	_	_	_	_
22-10	3471-3474	are	_	_	_	_
22-11	3475-3479	also	_	_	_	_
22-12	3480-3486	potent	abstract[174]	giv[174]	_	_
22-13	3487-3497	modulators	abstract[174]	giv[174]	_	_
22-14	3498-3500	of	abstract[174]	giv[174]	_	_
22-15	3501-3504	the	abstract[174]|object[175]	giv[174]|new[175]	coref	27-38[215_175]
22-16	3505-3515	intestinal	abstract[174]|object[175]	giv[174]|new[175]	_	_
22-17	3516-3526	microflora	abstract[174]|object[175]	giv[174]|new[175]	_	_
22-18	3527-3528	.	_	_	_	_

#Text=For instance , addition of prebiotic mannanoligosaccharides ( MOS ) to the diet of broilers reduced the severity of the infection due to either E. tenella alone or a mixture of E. acervulina , E. maxima , and E. tenella .
23-1	3529-3532	For	_	_	_	_
23-2	3533-3541	instance	_	_	_	_
23-3	3542-3543	,	_	_	_	_
23-4	3544-3552	addition	abstract[176]	new[176]	_	_
23-5	3553-3555	of	abstract[176]	new[176]	_	_
23-6	3556-3565	prebiotic	abstract[176]|substance|substance[178]	new[176]|new|new[178]	appos|appos	23-9[0_178]|23-9[0_178]
23-7	3566-3588	mannanoligosaccharides	abstract[176]|substance[178]	new[176]|new[178]	_	_
23-8	3589-3590	(	_	_	_	_
23-9	3591-3594	MOS	substance	giv	_	_
23-10	3595-3596	)	_	_	_	_
23-11	3597-3599	to	_	_	_	_
23-12	3600-3603	the	abstract[180]	new[180]	_	_
23-13	3604-3608	diet	abstract[180]	new[180]	_	_
23-14	3609-3611	of	abstract[180]	new[180]	_	_
23-15	3612-3620	broilers	abstract[180]|substance	new[180]|new	_	_
23-16	3621-3628	reduced	_	_	_	_
23-17	3629-3632	the	abstract[182]	new[182]	_	_
23-18	3633-3641	severity	abstract[182]	new[182]	_	_
23-19	3642-3644	of	abstract[182]	new[182]	_	_
23-20	3645-3648	the	abstract[182]|abstract[183]	new[182]|giv[183]	coref	32-37[274_183]
23-21	3649-3658	infection	abstract[182]|abstract[183]	new[182]|giv[183]	_	_
23-22	3659-3662	due	_	_	_	_
23-23	3663-3665	to	_	_	_	_
23-24	3666-3672	either	_	_	_	_
23-25	3673-3675	E.	_	_	_	_
23-26	3676-3683	tenella	_	_	_	_
23-27	3684-3689	alone	_	_	_	_
23-28	3690-3692	or	_	_	_	_
23-29	3693-3694	a	substance[184]	new[184]	_	_
23-30	3695-3702	mixture	substance[184]	new[184]	_	_
23-31	3703-3705	of	substance[184]	new[184]	_	_
23-32	3706-3708	E.	substance[184]	new[184]	_	_
23-33	3709-3719	acervulina	substance[184]	new[184]	_	_
23-34	3720-3721	,	substance[184]	new[184]	_	_
23-35	3722-3724	E.	substance[184]	new[184]	_	_
23-36	3725-3731	maxima	substance[184]	new[184]	_	_
23-37	3732-3733	,	substance[184]	new[184]	_	_
23-38	3734-3737	and	substance[184]	new[184]	_	_
23-39	3738-3740	E.	substance[184]	new[184]	_	_
23-40	3741-3748	tenella	substance[184]	new[184]	_	_
23-41	3749-3750	.	_	_	_	_

#Text=However , for the bioactives to be effective , these compounds have to be administered to the animals under fully controlled conditions and as early as possible .
24-1	3751-3758	However	_	_	_	_
24-2	3759-3760	,	_	_	_	_
24-3	3761-3764	for	_	_	_	_
24-4	3765-3768	the	substance[185]	new[185]	_	_
24-5	3769-3779	bioactives	substance[185]	new[185]	_	_
24-6	3780-3782	to	substance[185]	new[185]	_	_
24-7	3783-3785	be	substance[185]	new[185]	_	_
24-8	3786-3795	effective	substance[185]	new[185]	_	_
24-9	3796-3797	,	_	_	_	_
24-10	3798-3803	these	object[186]	new[186]	_	_
24-11	3804-3813	compounds	object[186]	new[186]	_	_
24-12	3814-3818	have	_	_	_	_
24-13	3819-3821	to	_	_	_	_
24-14	3822-3824	be	_	_	_	_
24-15	3825-3837	administered	_	_	_	_
24-16	3838-3840	to	_	_	_	_
24-17	3841-3844	the	animal[187]	giv[187]	_	_
24-18	3845-3852	animals	animal[187]	giv[187]	_	_
24-19	3853-3858	under	_	_	_	_
24-20	3859-3864	fully	abstract[188]	new[188]	coref	30-15[245_188]
24-21	3865-3875	controlled	abstract[188]	new[188]	_	_
24-22	3876-3886	conditions	abstract[188]	new[188]	_	_
24-23	3887-3890	and	_	_	_	_
24-24	3891-3893	as	_	_	_	_
24-25	3894-3899	early	_	_	_	_
24-26	3900-3902	as	_	_	_	_
24-27	3903-3911	possible	_	_	_	_
24-28	3912-3913	.	_	_	_	_

#Text=An innovative method for introducing bioactive substances into chickens is the in ovo injection into eggs intended for hatching .
25-1	3914-3916	An	abstract[189]	new[189]	ana	26-1[0_189]
25-2	3917-3927	innovative	abstract[189]	new[189]	_	_
25-3	3928-3934	method	abstract[189]	new[189]	_	_
25-4	3935-3938	for	_	_	_	_
25-5	3939-3950	introducing	_	_	_	_
25-6	3951-3960	bioactive	substance[190]	new[190]	coref	26-19[200_190]
25-7	3961-3971	substances	substance[190]	new[190]	_	_
25-8	3972-3976	into	_	_	_	_
25-9	3977-3985	chickens	animal	giv	coref	30-24[247_0]
25-10	3986-3988	is	_	_	_	_
25-11	3989-3992	the	event[193]	new[193]	coref	28-13[220_193]
25-12	3993-3995	in	event[193]	new[193]	_	_
25-13	3996-3999	ovo	object|event[193]	new|new[193]	coref	28-13
25-14	4000-4009	injection	event[193]	new[193]	_	_
25-15	4010-4014	into	event[193]	new[193]	_	_
25-16	4015-4019	eggs	event[193]|object	new[193]|new	_	_
25-17	4020-4028	intended	_	_	_	_
25-18	4029-4032	for	_	_	_	_
25-19	4033-4041	hatching	_	_	_	_
25-20	4042-4043	.	_	_	_	_

#Text=This is a technique that is based on the introduction on the appropriate day of embryonic development of bioactive substances into the air chamber of the egg or directly into the developing embryo .
26-1	4044-4048	This	abstract	giv	coref	26-3[196_0]
26-2	4049-4051	is	_	_	_	_
26-3	4052-4053	a	abstract[196]	giv[196]	coref	27-1[205_196]
26-4	4054-4063	technique	abstract[196]	giv[196]	_	_
26-5	4064-4068	that	_	_	_	_
26-6	4069-4071	is	_	_	_	_
26-7	4072-4077	based	_	_	_	_
26-8	4078-4080	on	_	_	_	_
26-9	4081-4084	the	event[197]	new[197]	_	_
26-10	4085-4097	introduction	event[197]	new[197]	_	_
26-11	4098-4100	on	event[197]	new[197]	_	_
26-12	4101-4104	the	event[197]|time[198]	new[197]|new[198]	_	_
26-13	4105-4116	appropriate	event[197]|time[198]	new[197]|new[198]	_	_
26-14	4117-4120	day	event[197]|time[198]	new[197]|new[198]	_	_
26-15	4121-4123	of	event[197]|time[198]	new[197]|new[198]	_	_
26-16	4124-4133	embryonic	event[197]|time[198]|event[199]	new[197]|new[198]|new[199]	coref	27-22[0_199]
26-17	4134-4145	development	event[197]|time[198]|event[199]	new[197]|new[198]|new[199]	_	_
26-18	4146-4148	of	event[197]|time[198]|event[199]	new[197]|new[198]|new[199]	_	_
26-19	4149-4158	bioactive	event[197]|time[198]|event[199]|substance[200]	new[197]|new[198]|new[199]|giv[200]	_	_
26-20	4159-4169	substances	event[197]|time[198]|event[199]|substance[200]	new[197]|new[198]|new[199]|giv[200]	_	_
26-21	4170-4174	into	event[197]|time[198]|event[199]	new[197]|new[198]|new[199]	_	_
26-22	4175-4178	the	event[197]|time[198]|event[199]|place[202]	new[197]|new[198]|new[199]|new[202]	_	_
26-23	4179-4182	air	event[197]|time[198]|event[199]|abstract|place[202]	new[197]|new[198]|new[199]|new|new[202]	coref	28-21
26-24	4183-4190	chamber	event[197]|time[198]|event[199]|place[202]	new[197]|new[198]|new[199]|new[202]	_	_
26-25	4191-4193	of	event[197]|time[198]|event[199]|place[202]	new[197]|new[198]|new[199]|new[202]	_	_
26-26	4194-4197	the	event[197]|time[198]|event[199]|place[202]|object[203]	new[197]|new[198]|new[199]|new[202]|new[203]	coref	27-11[207_203]
26-27	4198-4201	egg	event[197]|time[198]|event[199]|place[202]|object[203]	new[197]|new[198]|new[199]|new[202]|new[203]	_	_
26-28	4202-4204	or	_	_	_	_
26-29	4205-4213	directly	object[204]	new[204]	_	_
26-30	4214-4218	into	object[204]	new[204]	_	_
26-31	4219-4222	the	object[204]	new[204]	_	_
26-32	4223-4233	developing	object[204]	new[204]	_	_
26-33	4234-4240	embryo	object[204]	new[204]	_	_
26-34	4241-4242	.	_	_	_	_

#Text=This method allows for a precise and uniform delivery of the bioactive substance to all embryos at an early stage of development , which unifies the effects of prebiotics across the flock and ensures proper development of gut microflora in all chicks .
27-1	4243-4247	This	abstract[205]	giv[205]	_	_
27-2	4248-4254	method	abstract[205]	giv[205]	_	_
27-3	4255-4261	allows	_	_	_	_
27-4	4262-4265	for	_	_	_	_
27-5	4266-4267	a	abstract[206]	new[206]	_	_
27-6	4268-4275	precise	abstract[206]	new[206]	_	_
27-7	4276-4279	and	abstract[206]	new[206]	_	_
27-8	4280-4287	uniform	abstract[206]	new[206]	_	_
27-9	4288-4296	delivery	abstract[206]	new[206]	_	_
27-10	4297-4299	of	abstract[206]	new[206]	_	_
27-11	4300-4303	the	abstract[206]|object[207]	new[206]|giv[207]	coref	28-26[0_207]
27-12	4304-4313	bioactive	abstract[206]|object[207]	new[206]|giv[207]	_	_
27-13	4314-4323	substance	abstract[206]|object[207]	new[206]|giv[207]	_	_
27-14	4324-4326	to	abstract[206]|object[207]	new[206]|giv[207]	_	_
27-15	4327-4330	all	abstract[206]|object[207]|animal[208]	new[206]|giv[207]|new[208]	_	_
27-16	4331-4338	embryos	abstract[206]|object[207]|animal[208]	new[206]|giv[207]|new[208]	_	_
27-17	4339-4341	at	abstract[206]	new[206]	_	_
27-18	4342-4344	an	abstract[206]|abstract[209]	new[206]|new[209]	_	_
27-19	4345-4350	early	abstract[206]|abstract[209]	new[206]|new[209]	_	_
27-20	4351-4356	stage	abstract[206]|abstract[209]	new[206]|new[209]	_	_
27-21	4357-4359	of	abstract[206]|abstract[209]	new[206]|new[209]	_	_
27-22	4360-4371	development	abstract[206]|abstract[209]|event	new[206]|new[209]|giv	_	_
27-23	4372-4373	,	_	_	_	_
27-24	4374-4379	which	_	_	_	_
27-25	4380-4387	unifies	_	_	_	_
27-26	4388-4391	the	abstract[211]	new[211]	coref	29-1[231_211]
27-27	4392-4399	effects	abstract[211]	new[211]	_	_
27-28	4400-4402	of	abstract[211]	new[211]	_	_
27-29	4403-4413	prebiotics	abstract[211]|substance[212]	new[211]|new[212]	coref	28-16[221_212]
27-30	4414-4420	across	abstract[211]|substance[212]	new[211]|new[212]	_	_
27-31	4421-4424	the	abstract[211]|substance[212]|animal[213]	new[211]|new[212]|new[213]	_	_
27-32	4425-4430	flock	abstract[211]|substance[212]|animal[213]	new[211]|new[212]|new[213]	_	_
27-33	4431-4434	and	_	_	_	_
27-34	4435-4442	ensures	_	_	_	_
27-35	4443-4449	proper	event[214]	new[214]	_	_
27-36	4450-4461	development	event[214]	new[214]	_	_
27-37	4462-4464	of	event[214]	new[214]	_	_
27-38	4465-4468	gut	event[214]|object[215]	new[214]|giv[215]	_	_
27-39	4469-4479	microflora	event[214]|object[215]	new[214]|giv[215]	_	_
27-40	4480-4482	in	event[214]|object[215]	new[214]|giv[215]	_	_
27-41	4483-4486	all	event[214]|object[215]|animal[216]	new[214]|giv[215]|giv[216]	_	_
27-42	4487-4493	chicks	event[214]|object[215]|animal[216]	new[214]|giv[215]|giv[216]	_	_
27-43	4494-4495	.	_	_	_	_

#Text=Studies conducted in the temperate climatic condition have already revealed that in ovo injection of prebiotics and probiotics into the air cell during embryogenesis improves egg hatchability and modulate the optimal composition of the chicken â€™s microbiota , fully developed at hatching .
28-1	4496-4503	Studies	event	new	_	_
28-2	4504-4513	conducted	_	_	_	_
28-3	4514-4516	in	_	_	_	_
28-4	4517-4520	the	abstract[218]	new[218]	_	_
28-5	4521-4530	temperate	abstract[218]	new[218]	_	_
28-6	4531-4539	climatic	abstract[218]	new[218]	_	_
28-7	4540-4549	condition	abstract[218]	new[218]	_	_
28-8	4550-4554	have	_	_	_	_
28-9	4555-4562	already	_	_	_	_
28-10	4563-4571	revealed	_	_	_	_
28-11	4572-4576	that	_	_	_	_
28-12	4577-4579	in	_	_	_	_
28-13	4580-4583	ovo	object|event[220]	giv|giv[220]	coref|coref	30-7|30-7
28-14	4584-4593	injection	event[220]	giv[220]	_	_
28-15	4594-4596	of	event[220]	giv[220]	_	_
28-16	4597-4607	prebiotics	event[220]|substance[221]	giv[220]|giv[221]	coref	30-9[0_221]
28-17	4608-4611	and	event[220]|substance[221]	giv[220]|giv[221]	_	_
28-18	4612-4622	probiotics	event[220]|substance[221]|substance	giv[220]|giv[221]|new	_	_
28-19	4623-4627	into	event[220]	giv[220]	_	_
28-20	4628-4631	the	event[220]|place[224]	giv[220]|new[224]	_	_
28-21	4632-4635	air	event[220]|place|place[224]	giv[220]|giv|new[224]	_	_
28-22	4636-4640	cell	event[220]|place[224]	giv[220]|new[224]	_	_
28-23	4641-4647	during	event[220]|place[224]	giv[220]|new[224]	_	_
28-24	4648-4661	embryogenesis	event[220]|place[224]|event	giv[220]|new[224]|new	_	_
28-25	4662-4670	improves	_	_	_	_
28-26	4671-4674	egg	object|event[227]	giv|new[227]	_	_
28-27	4675-4687	hatchability	event[227]	new[227]	_	_
28-28	4688-4691	and	_	_	_	_
28-29	4692-4700	modulate	_	_	_	_
28-30	4701-4704	the	abstract[228]	new[228]	_	_
28-31	4705-4712	optimal	abstract[228]	new[228]	_	_
28-32	4713-4724	composition	abstract[228]	new[228]	_	_
28-33	4725-4727	of	abstract[228]	new[228]	_	_
28-34	4728-4731	the	abstract[228]|abstract[230]	new[228]|giv[230]	_	_
28-35	4732-4739	chicken	abstract[228]|animal[229]|abstract[230]	new[228]|new[229]|giv[230]	coref	29-8[232_229]
28-36	4740-4742	â€™s	abstract[228]|animal[229]|abstract[230]	new[228]|new[229]|giv[230]	_	_
28-37	4743-4753	microbiota	abstract[228]|abstract[230]	new[228]|giv[230]	_	_
28-38	4754-4755	,	_	_	_	_
28-39	4756-4761	fully	_	_	_	_
28-40	4762-4771	developed	_	_	_	_
28-41	4772-4774	at	_	_	_	_
28-42	4775-4783	hatching	_	_	_	_
28-43	4784-4785	.	_	_	_	_

#Text=These effects are reportedly stable throughout the chicken â€™s lifespan , influencing metabolic and immune responses of the host , resulting in improvement in performance and meat quality .
29-1	4786-4791	These	abstract[231]	giv[231]	_	_
29-2	4792-4799	effects	abstract[231]	giv[231]	_	_
29-3	4800-4803	are	_	_	_	_
29-4	4804-4814	reportedly	_	_	_	_
29-5	4815-4821	stable	_	_	_	_
29-6	4822-4832	throughout	_	_	_	_
29-7	4833-4836	the	abstract[233]	new[233]	_	_
29-8	4837-4844	chicken	animal[232]|abstract[233]	giv[232]|new[233]	_	_
29-9	4845-4847	â€™s	animal[232]|abstract[233]	giv[232]|new[233]	_	_
29-10	4848-4856	lifespan	abstract[233]	new[233]	_	_
29-11	4857-4858	,	_	_	_	_
29-12	4859-4870	influencing	_	_	_	_
29-13	4871-4880	metabolic	abstract	new	_	_
29-14	4881-4884	and	_	_	_	_
29-15	4885-4891	immune	abstract|abstract[236]	giv|new[236]	_	_
29-16	4892-4901	responses	abstract[236]	new[236]	_	_
29-17	4902-4904	of	abstract[236]	new[236]	_	_
29-18	4905-4908	the	abstract[236]|animal[237]	new[236]|giv[237]	_	_
29-19	4909-4913	host	abstract[236]|animal[237]	new[236]|giv[237]	_	_
29-20	4914-4915	,	_	_	_	_
29-21	4916-4925	resulting	_	_	_	_
29-22	4926-4928	in	_	_	_	_
29-23	4929-4940	improvement	abstract[238]	new[238]	_	_
29-24	4941-4943	in	abstract[238]	new[238]	_	_
29-25	4944-4955	performance	abstract[238]|abstract	new[238]|giv	coref	32-21[266_0]
29-26	4956-4959	and	abstract[238]	new[238]	_	_
29-27	4960-4964	meat	abstract[238]|substance|abstract[241]	new[238]|new|giv[241]	coref|coref|coref|coref	30-24|32-27[270_241]|30-24|32-27[270_241]
29-28	4965-4972	quality	abstract[238]|abstract[241]	new[238]|giv[241]	_	_
29-29	4973-4974	.	_	_	_	_

#Text=However , the efficacy of in ovo delivered prebiotics has been evaluated mainly under fully controlled disease-free experimental conditions in the temperate using meat type chickens .
30-1	4975-4982	However	_	_	_	_
30-2	4983-4984	,	_	_	_	_
30-3	4985-4988	the	abstract[242]	giv[242]	coref	32-3[259_242]
30-4	4989-4997	efficacy	abstract[242]	giv[242]	_	_
30-5	4998-5000	of	abstract[242]	giv[242]	_	_
30-6	5001-5003	in	abstract[242]	giv[242]	_	_
30-7	5004-5007	ovo	abstract[242]|abstract	giv[242]|giv	ana	31-5
30-8	5008-5017	delivered	_	_	_	_
30-9	5018-5028	prebiotics	substance	giv	coref	31-9
30-10	5029-5032	has	_	_	_	_
30-11	5033-5037	been	_	_	_	_
30-12	5038-5047	evaluated	_	_	_	_
30-13	5048-5054	mainly	_	_	_	_
30-14	5055-5060	under	_	_	_	_
30-15	5061-5066	fully	abstract[245]	giv[245]	coref	31-13[252_245]
30-16	5067-5077	controlled	abstract[245]	giv[245]	_	_
30-17	5078-5090	disease-free	abstract[245]	giv[245]	_	_
30-18	5091-5103	experimental	abstract[245]	giv[245]	_	_
30-19	5104-5114	conditions	abstract[245]	giv[245]	_	_
30-20	5115-5117	in	abstract[245]	giv[245]	_	_
30-21	5118-5121	the	abstract[245]	giv[245]	_	_
30-22	5122-5131	temperate	abstract[245]	giv[245]	_	_
30-23	5132-5137	using	_	_	_	_
30-24	5138-5142	meat	substance|animal[247]	giv|giv[247]	coref|coref|coref|coref	32-27|32-44[276_247]|32-27|32-44[276_247]
30-25	5143-5147	type	animal[247]	giv[247]	_	_
30-26	5148-5156	chickens	animal[247]	giv[247]	_	_
30-27	5157-5158	.	_	_	_	_

#Text=In this study , it was hypothesized that prebiotics perform differently under field conditions in the tropics where management and environmental factors predispose birds to enteric diseases .
31-1	5159-5161	In	_	_	_	_
31-2	5162-5166	this	abstract[248]	new[248]	_	_
31-3	5167-5172	study	abstract[248]	new[248]	_	_
31-4	5173-5174	,	_	_	_	_
31-5	5175-5177	it	abstract	giv	coref	32-7
31-6	5178-5181	was	_	_	_	_
31-7	5182-5194	hypothesized	_	_	_	_
31-8	5195-5199	that	_	_	_	_
31-9	5200-5210	prebiotics	substance	giv	coref	32-9[261_0]
31-10	5211-5218	perform	_	_	_	_
31-11	5219-5230	differently	_	_	_	_
31-12	5231-5236	under	_	_	_	_
31-13	5237-5242	field	place|abstract[252]	new|giv[252]	coref|coref	32-48[277_252]|32-48[277_252]
31-14	5243-5253	conditions	abstract[252]	giv[252]	_	_
31-15	5254-5256	in	abstract[252]	giv[252]	_	_
31-16	5257-5260	the	abstract[252]|place[253]	giv[252]|new[253]	_	_
31-17	5261-5268	tropics	abstract[252]|place[253]	giv[252]|new[253]	_	_
31-18	5269-5274	where	_	_	_	_
31-19	5275-5285	management	organization	new	_	_
31-20	5286-5289	and	_	_	_	_
31-21	5290-5303	environmental	abstract[255]	new[255]	_	_
31-22	5304-5311	factors	abstract[255]	new[255]	_	_
31-23	5312-5322	predispose	_	_	_	_
31-24	5323-5328	birds	animal[256]	new[256]	_	_
31-25	5329-5331	to	animal[256]	new[256]	_	_
31-26	5332-5339	enteric	animal[256]|object|abstract[258]	new[256]|new|new[258]	_	_
31-27	5340-5348	diseases	animal[256]|abstract[258]	new[256]|new[258]	_	_
31-28	5349-5350	.	_	_	_	_

#Text=Thus , the efficacy of in ovo delivered prebiotics , antibiotic-chick formula , and a combination of the two on growth performance , carcass traits , meat quality , and gut health in the face of a natural coccidiosis infection was assessed in Kuroiler chickens reared under field conditions in Uganda .
32-1	5351-5355	Thus	_	_	_	_
32-2	5356-5357	,	_	_	_	_
32-3	5358-5361	the	abstract[259]	giv[259]	_	_
32-4	5362-5370	efficacy	abstract[259]	giv[259]	_	_
32-5	5371-5373	of	abstract[259]	giv[259]	_	_
32-6	5374-5376	in	abstract[259]	giv[259]	_	_
32-7	5377-5380	ovo	abstract[259]|animal	giv[259]|giv	_	_
32-8	5381-5390	delivered	_	_	_	_
32-9	5391-5401	prebiotics	substance[261]	giv[261]	_	_
32-10	5402-5403	,	substance[261]	giv[261]	_	_
32-11	5404-5420	antibiotic-chick	substance[261]|substance[262]	giv[261]|new[262]	_	_
32-12	5421-5428	formula	substance[261]|substance[262]	giv[261]|new[262]	_	_
32-13	5429-5430	,	substance[261]	giv[261]	_	_
32-14	5431-5434	and	substance[261]	giv[261]	_	_
32-15	5435-5436	a	substance[261]|abstract[263]	giv[261]|new[263]	_	_
32-16	5437-5448	combination	substance[261]|abstract[263]	giv[261]|new[263]	_	_
32-17	5449-5451	of	substance[261]|abstract[263]	giv[261]|new[263]	_	_
32-18	5452-5455	the	substance[261]|abstract[263]|abstract[264]	giv[261]|new[263]|new[264]	_	_
32-19	5456-5459	two	substance[261]|abstract[263]|abstract[264]	giv[261]|new[263]|new[264]	_	_
32-20	5460-5462	on	substance[261]|abstract[263]|abstract[264]	giv[261]|new[263]|new[264]	_	_
32-21	5463-5469	growth	substance[261]|abstract[263]|abstract[264]|abstract|abstract[266]	giv[261]|new[263]|new[264]|giv|giv[266]	_	_
32-22	5470-5481	performance	substance[261]|abstract[263]|abstract[264]|abstract[266]	giv[261]|new[263]|new[264]|giv[266]	_	_
32-23	5482-5483	,	substance[261]|abstract[263]|abstract[264]	giv[261]|new[263]|new[264]	_	_
32-24	5484-5491	carcass	substance[261]|abstract[263]|abstract[264]|object|abstract[268]	giv[261]|new[263]|new[264]|new|giv[268]	_	_
32-25	5492-5498	traits	substance[261]|abstract[263]|abstract[264]|abstract[268]	giv[261]|new[263]|new[264]|giv[268]	_	_
32-26	5499-5500	,	substance[261]|abstract[263]|abstract[264]	giv[261]|new[263]|new[264]	_	_
32-27	5501-5505	meat	substance[261]|abstract[263]|abstract[264]|substance|abstract[270]	giv[261]|new[263]|new[264]|giv|giv[270]	_	_
32-28	5506-5513	quality	substance[261]|abstract[263]|abstract[264]|abstract[270]	giv[261]|new[263]|new[264]|giv[270]	_	_
32-29	5514-5515	,	substance[261]|abstract[263]|abstract[264]	giv[261]|new[263]|new[264]	_	_
32-30	5516-5519	and	substance[261]|abstract[263]|abstract[264]	giv[261]|new[263]|new[264]	_	_
32-31	5520-5523	gut	substance[261]|abstract[263]|abstract[264]|abstract|abstract[272]	giv[261]|new[263]|new[264]|giv|giv[272]	_	_
32-32	5524-5530	health	substance[261]|abstract[263]|abstract[264]|abstract[272]	giv[261]|new[263]|new[264]|giv[272]	_	_
32-33	5531-5533	in	substance[261]|abstract[263]|abstract[264]|abstract[272]	giv[261]|new[263]|new[264]|giv[272]	_	_
32-34	5534-5537	the	substance[261]|abstract[263]|abstract[264]|abstract[272]|abstract[273]	giv[261]|new[263]|new[264]|giv[272]|new[273]	_	_
32-35	5538-5542	face	substance[261]|abstract[263]|abstract[264]|abstract[272]|abstract[273]	giv[261]|new[263]|new[264]|giv[272]|new[273]	_	_
32-36	5543-5545	of	substance[261]|abstract[263]|abstract[264]|abstract[272]|abstract[273]	giv[261]|new[263]|new[264]|giv[272]|new[273]	_	_
32-37	5546-5547	a	substance[261]|abstract[263]|abstract[264]|abstract[272]|abstract[273]|abstract[274]	giv[261]|new[263]|new[264]|giv[272]|new[273]|giv[274]	_	_
32-38	5548-5555	natural	substance[261]|abstract[263]|abstract[264]|abstract[272]|abstract[273]|abstract[274]	giv[261]|new[263]|new[264]|giv[272]|new[273]|giv[274]	_	_
32-39	5556-5567	coccidiosis	substance[261]|abstract[263]|abstract[264]|abstract[272]|abstract[273]|abstract[274]	giv[261]|new[263]|new[264]|giv[272]|new[273]|giv[274]	_	_
32-40	5568-5577	infection	substance[261]|abstract[263]|abstract[264]|abstract[272]|abstract[273]|abstract[274]	giv[261]|new[263]|new[264]|giv[272]|new[273]|giv[274]	_	_
32-41	5578-5581	was	_	_	_	_
32-42	5582-5590	assessed	_	_	_	_
32-43	5591-5593	in	_	_	_	_
32-44	5594-5602	Kuroiler	object|animal[276]	new|giv[276]	_	_
32-45	5603-5611	chickens	animal[276]	giv[276]	_	_
32-46	5612-5618	reared	_	_	_	_
32-47	5619-5624	under	_	_	_	_
32-48	5625-5630	field	abstract[277]	giv[277]	_	_
32-49	5631-5641	conditions	abstract[277]	giv[277]	_	_
32-50	5642-5644	in	abstract[277]	giv[277]	_	_
32-51	5645-5651	Uganda	abstract[277]|place	giv[277]|giv	_	_
32-52	5652-5653	.	_	_	_	_
